SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 12
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 9 10 11 12
|
presentations:
1 to
50 of
582
|
VALIDATION OF RAPID SEMIQUANTITATIVE LATERAL FLOW ASSAY FOR URINE TENOFOVIR (ABSTRACT
352)
Derin Sevenler
Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
IMPLICATION OF MEASURING URINE TENOFOVIR BY RAPID LATERAL FLOW ASSAY FOR DOSE RECENCY (ABSTRACT
353)
Xin Niu
University of Washington, Seattle, USA
ESTABLISHING THE CUT-OFF FOR A URINE-BASED POINT-OF-CARE TEST FOR ADHERENCE TO TAF (ABSTRACT
354)
Matthew Spinelli
University of California San Francisco, San Francisco, CA, USA
URINE TENOFOVIR CONCENTRATIONS ARE LOWER AMONG INDIVIDUALS TAKING TAF THAN TDF (ABSTRACT
355)
Kelly Anne Johnson
University of California San Francisco, San Francisco, CA, USA
HAIR MASS SPECTROMETRY IMAGING CAPTURES SHORT- AND LONG-TERM PREP ADHERENCE CHANGES (ABSTRACT
356)
Elias Rosen
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
HAIR MASS SPECTROMETRY IMAGING OF DAILY MARAVIROC ADHERENCE IN HPTN 069/ACTG 5305 (ABSTRACT
357)
Elias Rosen
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
A SORTING SIGNAL IN THE SIV ENV TAIL IS SELECTED IN VIVO DURING PATHOGENIC INFECTION (ABSTRACT
199)
Scott P Lawrence
University College London, London, United Kingdom
ADOPTIVE TRANSFER OF GAMMA DELTA T CELLS ENHANCES HIV INFECTION IN A HUMANIZED MOUSE (ABSTRACT
200)
Shivkumar Biradar
University of Pittsburgh, Pittsburgh, PA, USA
EXPERIMENTAL MICROBIAL DYSBIOSIS ENHANCES RECTAL SIV ACQUISITION IN RHESUS MACAQUES (ABSTRACT
201)
Alexandra Ortiz
National Institutes of Health, Bethesda, MD, USA
FULLY QUANTITATIVE PET IMAGING UNRAVELS THE RELATIVE SIZE OF GUT CD4 POOL (ABSTRACT
202)
Michele Di Mascio
National Institutes of Health, Rockville, USA
PRE-ART VIRAL LOAD IS PREDICTIVE OF LYMPH NODE ART LEVELS IN SIV-INFECTED MACAQUES (ABSTRACT
203)
Sharat Srinivasula
Leidos Biomedical Research Incorporated, Rockville, MD, USA
ALTERED RESPONSE PATTERN FOLLOWING NONCANONICAL NF-ΚB ACTIVATION IN INFANT MACAQUES (ABSTRACT
204)
Katherine M Bricker
Emory University, Atlanta, GA, USA
TENOFOVIR DIPHOSPHATE IN DRIED BLOOD SPOTS PREDICTS FUTURE VIREMIA IN SOUTH AFRICA (ABSTRACT
398)
Reuben N Robbins
New York Psychiatric Institute and Columbia University, New York, NY, USA
EFFECTIVENESS OF THE DOLUTEGRAVIR TRANSITION IN UGANDA: DISCO COHORT WEEK-24 RESULTS (ABSTRACT
399)
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
DOLUTEGRAVIR IN REAL LIFE: QUALITY-OF-LIFE OUTCOMES IN A COHORT STUDY IN LESOTHO (ABSTRACT
400)
Jennifer A Brown
Swiss Tropical and Public Health Institute, Basel, Switzerland
IMPACT OF ANTIRETROVIRAL REGIMENS ON MORTALITY IN PATIENTS WITH ADVANCED HIV DISEASE (ABSTRACT
405)
Joaquin Burgos-Cibrian
Hospital University Vall d'Hebron, Barcelona, BARCELONA, Spain
EFFECTIVENESS OF RECOMMENDED 3-DRUG REGIMENS FOR TREATING ADVANCED HIV INFECTION (ABSTRACT
406)
Karam Mounzer
Jonathan Lax Center, Philadelphia, USA
BLIP INCIDENCE IN DOLUTEGRAVIR- OR EFAVIRENZ-BASED ART DURING ACUTE HIV INFECTION (ABSTRACT
407)
Bharat Nandakumar
University of Milan, Milan, Italy
HMMCGAG ASSAY DETECTS HIGH VIREMIA RATES ON ART STARTED DURING ACUTE HIV INFECTION (ABSTRACT
408)
Donn J Colby
Henry M. Jackson Foundation, Seattle, WA, USA
CURRENT ANTIRETROVIRAL TREATMENT AMONG PEOPLE WITH HIV IN CARE IN THE US (2018-2019) (ABSTRACT
409)
Jimmy Ma
University of Washington, Seattle, WA, USA
CHARACTERIZING FIRST VIRAL FAILURES AMONG ANTIRETROVIRAL THERAPY INITIATORS IN THE US (ABSTRACT
410)
Thibaut Davy-Mendez
University of California San Francisco, San Francisco, CA, USA
SECOND ANTIRETROVIRAL THERAPY REGIMEN IN VIREMIC PEOPLE WITH HIV IN THE US, 2008-2018 (ABSTRACT
411)
Thibaut Davy-Mendez
University of California San Francisco, San Francisco, CA, USA
DOLUTEGRAVIR AND VIRAL LOAD SUPPRESSION AMONG PEDIATRIC PATIENTS IN CARE IN ZAMBIA (ABSTRACT
600)
Shilpa S Iyer
University of Alabama at Birmingham, Lusaka, Zambia
SWITCHING EFAVIRENZ TO RILPIVIRINE IN VIROLOGICALLY SUPPRESSED ADOLESCENTS WITH HIV (ABSTRACT
601)
Wanatpreeya Phongsamart
Faculty of Medicine SIriraj Hospital, Bangkok, Thailand
MINDFULNESS TO IMPROVE ART ADHERENCE AND ACCEPTANCE IN YOUTH LIVING WITH HIV: AN RCT (ABSTRACT
602)
Erica Sibinga
Johns Hopkins School of Medicine, Baltimore, MD, USA
RANDOMIZED CONTROLLED TRIAL OF AN ADHERENCE INTERVENTION IN YOUTH LIVING WITH HIV (ABSTRACT
603)
K. Rivet Amico
University of Michigan, Ann Arbor, MI, USA
IMPAACT 2014 24-WEEK PK AND SAFETY OF DORAVIRINE/3TC/TDF IN ADOLESCENTS WITH HIV-1 (ABSTRACT
604)
Ann J Melvin
University of Washington, Seattle, WA, USA
ABACAVIR DOSING IN NEONATES FROM BIRTH: A PHARMACOKINETIC ANALYSIS (ABSTRACT
605)
Adrie Bekker
Stellenbosch University, Cape Town, South Africa
DOSE OPTIMISATION OF LONG-ACTING INJECTABLES IN NEONATES VIA PBPK MODELLING (ABSTRACT
606)
Fazila Sadik Bunglawala
University of Liverpool, Liverpool, United Kingdom
OPTIMIZING DOLUTEGRAVIR INITIATION IN NEONATES USING POPULATION PHARMACOKINETIC MODEL (ABSTRACT
607)
Joseph Piscitelli
Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA
POPULATION PHARMACOKINETICS OF VRC01LS IN TERM INFANTS AND ADULTS (ABSTRACT
608)
Jincheng Yang
University of California San Diego, La Jolla, CA, USA
SAFETY AND PHARMACOKINETICS OF VRC01LS AND 10-1074 AMONG CHILDREN IN BOTSWANA (ABSTRACT
609)
Edmund Capparelli
University of California San Diego, San Diego, CA, USA
A NOVEL EXTENDED-LENGTH HIV-1 PLASMA RNA SEQUENCING ASSAY (ABSTRACT
314)
Katie Fisher
Westmead Institute for Medical Research, Westmead, NSW, Australia
QUANTIFICATION BIAS IN HIV-1 PROVIRUSES BY NEAR FULL-LENGTH GENOME SEQUENCING METHODS (ABSTRACT
315)
Jennifer A White
Johns Hopkins, Baltimore, USA
IMPROVED DETECTION OF HIV GAG P24 PROTEIN FROM PATIENT-DERIVED SAMPLES (ABSTRACT
316)
Paul Zuck
Merck & Co, Inc, West Point, PA, USA
VASCULAR INJURY MARKERS ASSOCIATED WITH COGNITIVE IMPAIRMENT IN HIV PATIENTS ON ART (ABSTRACT
320)
Debjani Guha
Dana Farber Cancer Institute, Boston, MA, USA
SEX-SPECIFIC ASSOCIATIONS BETWEEN CSF MARKERS AND COGNITIVE FUNCTION IN PWH IN UGANDA (ABSTRACT
321)
Leah Rubin
Johns Hopkins Univeristy, Baltimore, MD, USA
CIRCULATING INTERMEDIATE MONOCYTES: A COGNITIVE BIOMARKER IN HIV-INFECTED WOMEN (ABSTRACT
322)
Rebecca Veenhuis
Johns Hopkins Univeristy, Baltimore, MD, USA
BASELINE MONOCYTE HIV RNA PREDICTS BLUNTED COGNITIVE TRAJECTORIES IN ACUTE INFECTION (ABSTRACT
323)
Ivo SahBandar
Weill Cornell Medicine, New York, NY, USA
GLYCA IS ASSOCIATED WITH NEUROPSYCHOLOGICAL IMPAIRMENT IN PREDOMINANTLY HIV+ MEN (ABSTRACT
324)
Albert M Anderson
Emory University School of Medicine, Atlanta, GA, USA
PREDICTED PATHOGENICITY OF MTDNA VARIANTS AND MOTOR IMPAIRMENT IN PERSONS WITH HIV (ABSTRACT
325)
Karen E Volpe
Vanderbilt University Medical Center, Nashville, TN, USA
BUCCAL MITOCHONDRIAL DNA IS ASSOCIATED WITH AMYLOID-Β 1-42 IN CEREBROSPINAL FLUID (ABSTRACT
326)
Dipesh Solanky
University of California San Diego, San Diego, CA, USA
CSF MARKERS OF AD-RELATED PATHOLOGY AND MEMORY DEFICITS IN OLDER PEOPLE WITH HIV (ABSTRACT
327)
Judith Diane Lobo
University of California San Diego, San Diego, CA, USA
ASSOCIATION BETWEEN INTEGRASE INHIBITORS (INSTIS) AND CARDIOVASCULAR DISEASE (CVD) (ABSTRACT
488)
Bastian Neesgaard
Rigshospitalet, Copenhagen, Denmark
INFLAMMATORY AND ATHEROGENESIS MARKERS 148 WEEKS POSTSWITCH TO DTG+RPV IN SWORD-1/ -2 (ABSTRACT
489)
Josep María Llibre
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
QUINOLINIC ACID IS ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN HIV (ABSTRACT
490)
Corrilynn O Hileman
MetroHealth Medical Center, Cleveland, OH, USA
HIV INFLAMMATORY PATHWAYS DIFFER ACCORDING TO SOCIOECONOMIC INDICES IN MALAWI (ABSTRACT
491)
Christine Kelly
University College Dublin, Dublin, Ireland
ASSESSING PROTEIN BIOMARKERS' ROLE IN CVD RISK PREDICTION IN PERSONS WITH HIV (PWH) (ABSTRACT
492)
Sandra E Safo
University of Minnesota, Minneapolis, MN, USA
ENDOTHELIAL MICROVESICLES: BIOMARKER & MEDIATOR OF ENDOTHELIAL DYSFUNCTION WITH HIV-1 (ABSTRACT
493)
Vinicius Pacheco Garcia
University of Colorado Boulder, Boulder, CO, USA
MODULATION OF GUT FLORA PROMOTES THE REGRESSION OF ANAL DYSPLASIA IN HIV+ MSM (ABSTRACT
470)
Eugenio Nelson Cavallari
Sapienza University of Rome, Rome, Italy
|
<< first | < prev
page:
of 12
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 9 10 11 12
|
presentations:
1 to
50 of
582
|
